Skip to content
10-Q

Quarterly Report

LEXICON PHARMACEUTICALS, INC. LXRX

0001628280-25-038340

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 363.4M sh
Shares Diluted Q2 2025 · Jun 30, 2025 363.57M sh
Shares Diluted Q2 2025 · Jun 30, 2025 362.69M sh
Shares Diluted Q2 2025 · Jun 30, 2024 310.84M sh
Shares Diluted Q2 2025 · Jun 30, 2024 278.11M sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $250K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$26.79M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$103.67M
Long Term Debt Q2 2025 · Jun 30, 2025 $56.11M
Long Term Debt Q2 2025 · Dec 31, 2024 $100.3M
Short Term Investments Q2 2025 · Jun 30, 2025 $117.64M
Short Term Investments Q2 2025 · Dec 31, 2024 $171.3M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $21.36M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $66.66M
Stockholders Equity Q2 2025 · Jun 30, 2025 $129.44M
Stockholders Equity Q2 2025 · Dec 31, 2024 $145.95M
Current Liabilities Q2 2025 · Jun 30, 2025 $34.84M
Current Liabilities Q2 2025 · Dec 31, 2024 $45.25M
Total Liabilities Q2 2025 · Jun 30, 2025 $96.14M
Total Liabilities Q2 2025 · Dec 31, 2024 $152.47M
Current Assets Q2 2025 · Jun 30, 2025 $145.08M
Current Assets Q2 2025 · Dec 31, 2024 $246.19M
Total Assets Q2 2025 · Jun 30, 2025 $225.58M
Total Assets Q2 2025 · Dec 31, 2024 $298.42M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.01
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.06
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.17
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.37
Eps Basic Q2 2025 · Jun 30, 2025 $0.01
Eps Basic Q2 2025 · Jun 30, 2025 −$0.06
Eps Basic Q2 2025 · Jun 30, 2024 −$0.17
Eps Basic Q2 2025 · Jun 30, 2024 −$0.37
Sga Expense Q2 2025 · Jun 30, 2025 $9.35M
Sga Expense Q2 2025 · Jun 30, 2025 $20.96M
Sga Expense Q2 2025 · Jun 30, 2024 $39.19M
Sga Expense Q2 2025 · Jun 30, 2024 $71.25M
Rd Expense Q2 2025 · Jun 30, 2025 $15.75M
Rd Expense Q2 2025 · Jun 30, 2025 $31.05M
Rd Expense Q2 2025 · Jun 30, 2024 $17.64M
Rd Expense Q2 2025 · Jun 30, 2024 $32.02M
Net Income Q2 2025 · Jun 30, 2025 $3.25M
Net Income Q2 2025 · Jun 30, 2025 −$22.04M
Net Income Q2 2025 · Mar 31, 2025 −$25.3M
Net Income Q2 2025 · Jun 30, 2024 −$53.43M
Net Income Q2 2025 · Jun 30, 2024 −$101.83M
Net Income Q2 2025 · Mar 31, 2024 −$48.4M
Operating Income Q2 2025 · Jun 30, 2025 $3.74M
Operating Income Q2 2025 · Jun 30, 2025 −$21.94M
Operating Income Q2 2025 · Jun 30, 2024 −$55.35M
Operating Income Q2 2025 · Jun 30, 2024 −$100.69M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $33K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $63K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $166K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $197K